These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30487328)

  • 41. [Glucocorticoid and Bone. Beneficial effect of teriparatide on fracture risk as well as bone mineral density in patients with glucocorticoid-induced osteoporosis].
    Yamamoto M; Sugimoto T
    Clin Calcium; 2014 Sep; 24(9):1379-85. PubMed ID: 25177011
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cushing's syndrome of nonpituitary causes.
    Carroll TB; Findling JW
    Curr Opin Endocrinol Diabetes Obes; 2009 Aug; 16(4):308-15. PubMed ID: 19491665
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Prophylaxis of glucocorticoid-induced osteoporosis].
    Tanaka Y
    Clin Calcium; 2006 Nov; 16(11):1858-65. PubMed ID: 17079853
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Secondary osteoporosis UPDATE. How to diagnose secondary osteoporosis and disorders presenting low bone mineral density].
    Takeuchi Y
    Clin Calcium; 2010 May; 20(5):665-71. PubMed ID: 20445277
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glucocorticoid excess and hypertension.
    Baid S; Nieman LK
    Curr Hypertens Rep; 2004 Dec; 6(6):493-9. PubMed ID: 15527696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cushing's syndrome.
    STRICKLAND B
    Proc R Soc Med; 1954 May; 47(5):341-5. PubMed ID: 13167050
    [No Abstract]   [Full Text] [Related]  

  • 47. Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis.
    Amiche MA; Albaum JM; Tadrous M; Pechlivanoglou P; Lévesque LE; Adachi JD; Cadarette SM
    Osteoporos Int; 2016 Jun; 27(6):1989-98. PubMed ID: 26782683
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Therapeutic strategy for glucocorticoid-induced osteoporosis].
    Hayakawa N; Suzuki A
    Clin Calcium; 2013 Sep; 23(9):1337-44. PubMed ID: 23999371
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glucocorticoid-induced osteoporosis management among seniors, by year, sex, and indication, 1996-2012.
    Albaum JM; Lévesque LE; Gershon AS; Liu G; Cadarette SM
    Osteoporos Int; 2015 Dec; 26(12):2845-52. PubMed ID: 26138581
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Body composition and bone mineral density in women with Cushing's syndrome in remission and the association with common genetic variants influencing glucocorticoid sensitivity.
    Ragnarsson O; Glad CA; Bergthorsdottir R; Almqvist EG; Ekerstad E; Widell H; Wängberg B; Johannsson G
    Eur J Endocrinol; 2015 Jan; 172(1):1-10. PubMed ID: 25422351
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Glucocorticoid and bone metabolism and disease].
    Tanaka Y
    Clin Calcium; 2013 Feb; 23(2):229-35. PubMed ID: 23354090
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel approaches to bone comorbidity in Cushing's disease: an update.
    Frara S; di Filippo L; Doga M; Loli P; Casanueva FF; Giustina A
    Pituitary; 2022 Oct; 25(5):754-759. PubMed ID: 35849272
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Glucocorticoid-induced osteoporosis].
    Suzuki Y
    Nihon Rinsho; 2015 Oct; 73(10):1733-9. PubMed ID: 26529939
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Glucocorticoid induced osteoporosis].
    Lange U; Müller-Ladner U
    Orthopade; 2007 Apr; 36(4):381-8; quiz 389-90. PubMed ID: 17665509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glucocorticoid induced risk of fractures.
    Maruotti N; Corrado A; Cantatore FP
    Panminerva Med; 2010 Dec; 52(4):339-43. PubMed ID: 21183894
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Osteoporosis in Cushing's syndrome].
    Tomita A; Takatsuki K
    Nihon Rinsho; 1990 Dec; 48(12):2877-81. PubMed ID: 2086848
    [No Abstract]   [Full Text] [Related]  

  • 57. [Secondary osteoporosis. Surgical treatment for patients with secondary osteoporosis.].
    Noda S; Onoda N; Ohira M
    Clin Calcium; 2018; 28(12):1671-1677. PubMed ID: 30487334
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypertension in Cushing's syndrome.
    Magiakou MA; Smyrnaki P; Chrousos GP
    Best Pract Res Clin Endocrinol Metab; 2006 Sep; 20(3):467-82. PubMed ID: 16980206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [CUSHING'S SYNDROME WITH PREDOMINANCE OF BONE MANIFESTATIONS].
    TAPELLA PA
    Prensa Med Argent; 1963 Jul; 50():2042-50. PubMed ID: 14104581
    [No Abstract]   [Full Text] [Related]  

  • 60. [Isolated osteoporosis in a case with Cushing's disease: development after treatment].
    Navarranne A; Tabarin A; Lafage MH; Roger P
    Ann Endocrinol (Paris); 1991; 52(2):113-8. PubMed ID: 1929194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.